Mattsson A, Sylvan SE, Axelsson P, Ellin F, et al. Idelalisib (PI3Kdelta inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients. Eur J Haematol 2023 Jul 27. doi: 10.1111/ejh.14065.
PMID: 37501508